5 Oversold Stocks to Buy Right Now

4. Zoetis Inc. (NYSE:ZTS)

Number of Hedge Fund Holders: 57

Zoetis Inc. (NYSE:ZTS) is one of the oversold stocks to buy right now. On May 28, Zoetis received approval from the UK’s Veterinary Medicines Directorate for Lenivia (izenivetmab), a new long-acting monoclonal antibody therapy for alleviating osteoarthritis pain in dogs. Administered as a single injection, the treatment targets nerve growth factor to provide effective pain relief and improved mobility for up to three months.

Osteoarthritis is a prevalent, chronic joint disease affecting nearly 40% of dogs, significantly impacting their quality of life, mobility, and behavior. By offering a long-acting injectable option, Lenivia provides veterinary professionals with a flexible tool to support sustained comfort and manage pain as part of an individualized care plan.

This approval represents a major milestone in the company’s commitment to veterinary innovation and its expanding portfolio of monoclonal antibody therapies. Lenivia is expected to serve as a key advancement in canine pain management, helping address the significant unmet medical needs of dogs suffering from progressive joint conditions.

Zoetis Inc. (NYSE:ZTS) is a global animal health company that focuses on the discovery, development, manufacture, and commercialization of vaccines, medicines, biodevices, genetic tests, diagnostic products, and precision animal health. Its operations are divided into the United States and International segments.